Author Question: A patient has a platelet count of 80 x 109/L and a bleeding time of 15 minutes. From what is the ... (Read 56 times)

nelaaney

  • Hero Member
  • *****
  • Posts: 560
A patient has a platelet count of 80 x 109/L and a bleeding time of 15 minutes. From what is the patient most likely suffering?
 
  a. A platelet function disorder
  b. A quantitative platelet disorder
  c. A combined platelet disorder
  d. von Willebrand disease

Question 2

A 35-year-old female is hospitalized for knee replacement surgery. Preoperative blood tests reveal a platelet count of 64 x 109/L. The surgery is postponed, and the platelet count is repeated two days later when it is 48 x 109/L.
 
  All other labs appear normal. Based on this information, from what is the patient most likely suffering?
 
  a. Acute ITP
  b. Chronic ITP
  c. TTP
  d. HUS



livaneabi

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

Correct Answer: C

Answer to Question 2

Correct Answer: B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library